Skip to main content

Table 2 Number of doses of pneumococcal vaccine received by 421 NP-swabbed PCV7 children and 443 NP-swabbed PHiD-CV10 children

From: Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine

Doses of PCV7

Doses of PHiD-CV10

TOTAL

 

0

1

2

3

4

 

0

30c

18 c

48

278

78

404

1

4 c

2 c

23

15

1

39

2

26

13

30 c

  

39

3

305

72

1 c

  

377b

4

4

1

   

5

+ PPV23a

132a

     

+ PCV13b

2b

0

19b

69b

1b

91b

TOTAL

335

86

71

293

79

864

  1. PCV7 7-valent pneumococcal conjugate vaccine
  2. PHiD-CV10 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine
  3. PCV13 13-valent pneumococcal conjugate vaccine
  4. Included mixed schedules:
  5. a 132 swabbed children also received one dose PPV23 (ceased in October 2010)
  6. b 91 swabbed children also received one dose PCV13:
  7. 2 of 305 PCV7 3-dose children
  8. 19 of 48 PHiD-CV10 2-dose children
  9. 69 of 278 PHiD-CV10 3-dose children
  10. 1 of 78 PHiD-CV10 4-dose child
  11. Excluded schedules
  12. c 85 swabbed children were excluded, plus two additional children (not shown in Table 1) who received two doses of PHiD-CV10 and two doses of PCV13
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us